Watch (Dutch & English): Just five companies developing the bulk of urgently needed new medicines
Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation talks to NOS News about one of the key findings of the 2018 Access to Medicine Index: just five pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor.
“It’s a problem when its concentrated on these five because if any one of them changes their strategy, it can have a really catastrophic effect on our ability to bring innovation to the table and our ability to progress on access to medicine.” - Jayasree K. Iyer.